AK Medical (01789) saw its shares rise more than 8% again. At the time of writing, the stock was up 7.92%, trading at HK$6.27, with a turnover of HK$62.899 million. The company previously released its annual results, reporting full-year revenue of RMB 1.482 billion, a year-on-year increase of 10.1%. Profit attributable to equity shareholders was RMB 339 million, up 23.8% compared to the previous year. The significant profit growth was mainly driven by higher revenue and improved gross profit margin, attributed to increased income from overseas and digital orthopedic customized products and services. Notably, sales revenue from orthopedic surgical robots grew by over 200%. GF Securities noted in a research report that the company’s dual-brand strategy, "AK + JRI," is actively providing overseas customers with products and services such as 3D-printed customized prostheses and orthopedic surgical robots. The company has already sold three surgical robots in the international market, with several additional orders in the pipeline, highlighting the growth potential of orthopedic surgical robots and high-brand-value products globally.